W
William Borkowsky
Researcher at New York University
Publications - 215
Citations - 10325
William Borkowsky is an academic researcher from New York University. The author has contributed to research in topics: Viral load & Vaccination. The author has an hindex of 51, co-authored 214 publications receiving 9992 citations. Previous affiliations of William Borkowsky include Cornell University & State University of New York Upstate Medical University.
Papers
More filters
Journal ArticleDOI
Usefulness of Urinary Immune Biomarkers in the Evaluation of Neonatal Sepsis A Pilot Project
TL;DR: Urinary IL-8, IP-10, and MCP-1 are proinflammatory cytokines that are increased in the neonate during an infectious inflammatory process that may be useful predictors as an adjunct to the current protocols to recognize neonatal sepsis.
Journal Article
Live attenuated varicella vaccine in children with leukemia in remission.
Anne A. Gershon,Sharon Steinberg,George J. Galasso,William Borkowsky,P. LaRussa,Angelo Ferrara,Lawrence D. Gelb +6 more
TL;DR: One-hundred-ninety-one children with acute leukemia in remission for at least one year were immunized with 1 or more doses of live attenuated varicella vaccine, with the only significant side effect being mild to moderate rash.
Journal ArticleDOI
Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro
TL;DR: It is shown that low doses of bestatin (1 μg/ml) can completely inhibit viral infection resulting either from inoculation with free virus or coculture with infected lymphocytes, and appears to act in the early stages of viral penetration.
Journal ArticleDOI
Varicella does not appear to be a cofactor for human immunodeficiency virus infection in children.
Jane Ellen Aronson,George McSherry,Laura Hoyt,Mary G. Boland,James M. Oleske,Edward M. Connor,Deborah Persaud,William Borkowsky,Keith Krasinski,Saroj S. Bakshi,Jane Pitt,Anne A. Gershon +11 more
TL;DR: Retrospective analysis of longitudinal clinical and immunologic data obtained from 22 children in the early stages of infection with human immunodeficiency virus (HIV) when they developed varicella suggests that children with early HIV infection could be considered for immunization with live attenuated varICElla vaccine, which would be predicted to decrease their morbidity from variceella-zoster virus.
Journal ArticleDOI
A Comparison of Metabolic Outcomes Between Obese HIV-Exposed Uninfected Youth From the PHACS SMARTT Study and HIV-Unexposed Youth From the NHANES Study in the United States.
Jennifer Jao,Denise L. Jacobson,Wendy Yu,William Borkowsky,Mitchell E. Geffner,Elizabeth J. McFarland,Kunjal Patel,Paige L. Williams,Tracie L. Miller +8 more
TL;DR: In the United States, obese HEU youth seem to have an increased risk of hypertension, but lower risk of insulin resistance and hypercholesterolemia, compared with a general obese pediatric population.